characteristics.text: SAMN43260596
characteristics.characteristic: External Id
characteristics.text: Hideo Watanabe, Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai
characteristics.characteristic: INSDC center name
characteristics.text: 2025-05-14T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-05-14T15:56:04.947Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS22398886
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS22398886
characteristics.characteristic: SRA accession
characteristics.text: PC9 and NCI-H358
characteristics.characteristic: cell line
characteristics.text: tumor cell line
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: PC9 and NCI-H358
characteristics.characteristic: source_name
characteristics.text: PC9 and H358, cell hashing (HTO)
characteristics.characteristic: title
characteristics.text: untreated, 150nM Osimertinib treated for 4 or 11 days, or 500nM Sotorasib treated for 8 days
characteristics.characteristic: treatment